Oliver Lagore Vanvalin Investment Group’s Fulgent Genetics FLGT Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$7.1K	Buy	+420	New	+$8.19K	﹤0.01%	457

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's FLGT Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Fulgent Genetics (FLGT) in Q2 2025: 420 shares worth $7.1K. The stake represents ﹤0.01% of the portfolio and ranks #457 among its holdings.

167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

Oliver Lagore Vanvalin Investment Group held 420 shares of Fulgent Genetics worth $7.1K as of Q2 2025.
Fulgent Genetics was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
Fulgent Genetics made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #457 holding.
167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.